Get ready for an innovation in lashes.
LATISSE® (bimatoprost ophthalmic solution) 0.03% is
the first and only prescription treatment approved by the FDA for
inadequate or not having enough eyelashes, growing them longer, fuller
LATISSE® works effectively.
LATISSE® makes lash growth possible because of its
active ingredient: bimatoprost. Although the precise mechanism of action
is not known, research suggests that the growth of eyelashes occurs by
increasing the percent of hairs in, and the duration of, the anagen (or
growth) phase. Lashes can grow longer, thicker and darker because
bimatoprost can also prolong this growth phase.
Clinically proven results you can see over time.
LATISSE® is FDA approved and effective. It's a
once-a-day treatment you apply topically to the base of your upper
eyelashes. Patients in a clinical trial saw results in as few as 8 weeks
with full results after 12 to 16 weeks.
It's an innovation backed by research.
While LATISSE® is a treatment for inadequate or not
enough eyelashes; it was developed through years of research by
Allergan, a pharmaceutical leader with over 60 years of expertise in
prescription eye care products.
In the clinical study, 78% of participants
experienced a significant increase in overall eyelash prominence
(including elements of length, fullness, and darkness) at week 16.